Skip to main content
FinSpry Logo
FinSpry
CASI logo
CASI
(NASDAQ)
CASI Pharmaceuticals, Inc.
$0.14-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CASI Pharmaceuticals (CASI) Stock Price & Financial Analysis

CASI Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.13 - $0.15
52-Week High$3.09
52-Week Low$0.05
Open$0.13
Volume1.03K
Average Volume (3M)15.98K
Market Cap2.28M
Shares Outstanding16.05M
Price to Sales (P/S)0.08
Price to Book (P/B)-0.08
EV/EBITDA-0.39
Revenue (TTM)26.85M
Net Income (TTM)-49.38M
EPS (TTM)$-3.16
Profit Margin-183.93%
Operating Margin-164.27%
50-Day MA$0.22
200-Day MA$1.12
52-Week Change-92.88%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About CASI Pharmaceuticals

What is the current stock price for CASI?

As of the latest trading session, CASI stock trades at $0.14. The 52-week range is $0.05–$3.09, with a day range of $0.13–$0.15.

What is the P/E ratio for CASI?

The P/E ratio (Price-to-Earnings) for CASI is shown in the Key Statistics section. This valuation metric helps compare CASI Pharmaceuticals, Inc. to industry peers.

Does CASI pay dividends?

CASI Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CASI?

Analyst ratings and recommendations for CASI are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CASI?

CASI Pharmaceuticals's market capitalization is $2.3M, classifying it as a micro-cap company. CASI Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.